hiPSC-Derived Cardiomyocyte Model of LQT2 Syndrome Derived from Asymptomatic and Symptomatic Mutation Carriers Reproduces Clinical Differences in Aggregates but Not in Single Cells
Open accessThe DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Abstract
Mutations in the HERG gene encoding the potassium ion channel HERG, represent one of the most frequent causes of long QT syndrome type-2 (LQT2). The same genetic mutation frequently presents different clinical phenotypes in the family. Our study aimed to model LQT2 and study functional differences between the mutation carriers of variable clinical phenotypes. We derived human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CM) from asymptomatic and symptomatic HERG mutation carriers from the same family. When comparing asymptomatic and symptomatic single LQT2 hiPSC-CMs, results from allelic imbalance, potassium current density, and arrhythmicity on adrenaline exposure were similar, but a difference in Ca2+ transients was observed. The major differences were, however, observed at aggregate level with increased susceptibility to arrhythmias on exposure to adrenaline or potassium channel blockers on CM aggregates derived from the symptomatic individual. The effect of this mutation was modeled in-silico which indicated the reactivation of an inward calcium current as one of the main causes of arrhythmia. Our in-vitro hiPSC-CM model recapitulated major phenotype characteristics observed in LQT2 mutation carriers and strong phenotype differences between LQT2 asymptomatic vs. symptomatic were revealed at CM-aggregate level.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Traditionally, animal models, primary cells, embryonic stem cells (ESC), and immortalized cell lines derived from tumor cells are used to model a variety of human diseases [8,9,10,11].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Type-2 LQTS patients’ iPSC-derived cardiomyocytes showed that a mutation in KCNH2 causes action-potential-duration prolongation by reducing the cardiac potassium current IKr and dysfunction of the sodium ion channel [7,8,9].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [9]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome
Curran, M. E., Splawski, I., Timothy, K. W., Vincen, G. M., Green, E. D., & Keating, M. T. (1995) · Cell · doi:10.1016/0092-8674(95)90358-5 · Cited by 2,259 · cited 1×
“LQT2 is a channelopathy with a mutation in the HERG gene on chromosome 7 [9,10].”
BackgroundAl-Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T., Field, M. E., Fonarow, G. C., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.10.054 · Cited by 1,854
Schwartz, P. J., Priori, S. G., Spazzolini, C., Moss, A. J., Vincent, G. M., Napolitano, C., Denjoy, I., Guicheney, P., Breithardt, G., Keating, M. T., et al. (2001) · Circulation · doi:10.1161/01.cir.103.1.89 · Cited by 1,779
Patient-Specific Induced Pluripotent Stem-Cell Models for Long-QT Syndrome
Moretti, A., Bellin, M., Welling, A., Jung, C. B., Lam, J. T., Bott-Flügel, L., Dorn, T., Goedel, A., Höhnke, C., Hofmann, F., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908679 · Cited by 1,251 · cited 2×
“The expression ratios of HERG Finnish founder mutation (FinA) (p.L552S mutation) and HERG-wild type (WT) alleles were determined by plasmid-derived standard curve method (Moretti et al. 2010).”
BackgroundMethodSpectrum of Mutations in Long-QT Syndrome Genes: KVLQT1 , HERG , SCN5A , KCNE1 , and KCNE2
Splawski, I., Shen, J., Timothy, K. W., Lehmann, M. H., Priori, S., Robinson, J. L., Moss, A. J., Schwartz, P. J., Towbin, J. A., Vincent, G. M., et al. (2000) · Circulation · doi:10.1161/01.cir.102.10.1178 · Cited by 1,231
Prevalence of the Congenital Long-QT Syndrome
Schwartz, P. J., Stramba-Badiale, M., Crotti, L., Pedrazzini, M., Besana, A., Bosi, G., Gabbarini, F., Goulene, K., Insolia, R., Mannarino, S., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.863209 · Cited by 1,072
Modelling the long QT syndrome with induced pluripotent stem cells
Itzhaki, I., Maizels, L., Huber, I., Zwi-Dantsis, L., Caspi, O., Winterstern, A., Feldman, O., Gepstein, A., Arbel, G., Hammerman, H., et al. (2011) · Nature · doi:10.1038/nature09747 · Cited by 1,049 · cited 1×
“Human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) have been shown to recapitulate disease phenotypes of inherited cardiac diseases such as long QT syndrome and catecholamine polymorphic ventricular tachycardia (CPVT) [24–29].”
BackgroundAl-Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T., Field, M. E., Fonarow, G. C., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000549 · Cited by 724
Mummery, C. L., Zhang, J., Ng, E. S., Elliott, D. A., Elefanty, A. G., & Kamp, T. J. (2012) · Circulation Research · doi:10.1161/circresaha.110.227512 · Cited by 713 · cited 1×
“Human-induced pluripotent stem cells (hiPSCs) were di (cid:11) erentiated into CMs by the mouse endoderm-like cell line END-2 co-culture method [32] on mouse embryonic fibroblast (MEF) feeder cells (CellSystems, Troisdorf, Germany).”
MethodAl-Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T., Field, M. E., Fonarow, G. C., et al. (2018) · Heart Rhythm · doi:10.1016/j.hrthm.2017.10.036 · Cited by 629
Cryo-EM Structure of the Open Human Ether-à-go-go -Related K + Channel hERG
Wang, W., & MacKinnon, R. (2017) · Cell · doi:10.1016/j.cell.2017.03.048 · Cited by 500 · cited 1×
“…HERG channel, being a membrane protein, is di (cid:14) cult to crystallize and currently no crystal structure exists in the Protein Data Bank (PDB) and only recently studies on homology models or Cryogenic electron microscopy (cryo-EM) structures of the HERG structure have been published [40,41].”
BackgroundSpectrum of HERG K+-channel dysfunction in an inherited cardiac arrhythmia.
Sanguinetti, M. C., Curran, M. E., Spector, P. S., & Keating, M. T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.5.2208 · Cited by 473 · cited 1×
“LQT2 is a channelopathy with a mutation in the HERG gene on chromosome 7 [9,10].”
BackgroundThe genetic basis of long QT and short QT syndromes: A mutation update
Hedley, P. L., Jørgensen, P., Schlamowitz, S., Wangari, R., Moolman-Smook, J., Brink, P. A., Kanters, J. K., Corfield, V. A., & Christiansen, M. (2009) · Human Mutation · doi:10.1002/humu.21106 · Cited by 429 · cited 1×
“More than 300 mutations have been found in the HERG gene that could induce LQT2 [11,12].”
BackgroundMoss, A. J., Zareba, W., Kaufman, E. S., Gartman, E., Peterson, D. R., Benhorin, J., Towbin, J. A., Keating, M. T., Priori, S. G., Schwartz, P. J., et al. (2002) · Circulation · doi:10.1161/hc0702.105124 · Cited by 397
Matsa, E., Rajamohan, D., Dick, E., Young, L., Mellor, I., Staniforth, A., & Denning, C. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr073 · Cited by 389
Goldenberg, I., Horr, S., Moss, A. J., Lopes, C. M., Barsheshet, A., McNitt, S., Zareba, W., Andrews, M. L., Robinson, J. L., Locati, E. H., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.07.038 · Cited by 332 · cited 2×
“Clinically, around 25% of patients of all LQTS-carrying genetic mutations have a normal QT interval, and they do not present a disease phenotype, although they might still retain an increased risk of having cardiac events [20].”
BackgroundLahti, A. L., Kujala, V. J., Chapman, H., Koivisto, A.-P., Pekkanen-Mattila, M., Kerkelä, E., Hyttinen, J., Kontula, K., Swan, H., Conklin, B. R., et al. (2012) · Disease Models & Mechanisms · doi:10.1242/dmm.008409 · Cited by 288 · cited 1×
“WT) was characterized previously [28,31].”
Self-citationGenotype-Phenotype Aspects of Type 2 Long QT Syndrome
Shimizu, W., Moss, A. J., Wilde, A. A. M., Towbin, J. A., Ackerman, M. J., January, C. T., Tester, D. J., Zareba, W., Robinson, J. L., Qi, M., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.08.028 · Cited by 264 · cited 6×
“[4,11,13,14].”
BackgroundInfluentialTakenaka, K., Ai, T., Shimizu, W., Kobori, A., Ninomiya, T., Otani, H., Kubota, T., Takaki, H., Kamakura, S., & Horie, M. (2003) · Circulation · doi:10.1161/01.cir.0000048142.85076.a2 · Cited by 259 · cited 1×
“LQTS type2 (LQT2) is the second most common cause of LQTS with symptoms of syncope, seizures and sudden cardiac death due to ventricular arrhythmia [4–8].”
BackgroundKCNH2 -K897T Is a Genetic Modifier of Latent Congenital Long-QT Syndrome
Crotti, L., Lundquist, A. L., Insolia, R., Pedrazzini, M., Ferrandi, C., De Ferrari, G. M., Vicentini, A., Yang, P., Roden, D. M., George, A. L., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.549071 · Cited by 243 · cited 3×
“Clinically, the increased risk of arrhythmias for females has been reported [3,4,15–19] but in in-vitro experiments the e (cid:11) ect of the gender from whom the hiPSC-CMs are derived, and its e (cid:11) ect on CM-function remains to be investigated.”
BackgroundLiang, P., Sallam, K., Wu, H., Li, Y., Itzhaki, I., Garg, P., Zhang, Y., Termglichan, V., Lan, F., Gu, M., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.07.779 · Cited by 214
Large-scale mutational analysis of Kv11.1 reveals molecular insights into type 2 long QT syndrome
Anderson, C. L., Kuzmicki, C. E., Childs, R. R., Hintz, C. J., Delisle, B. P., & January, C. T. (2014) · Nature Communications · doi:10.1038/ncomms6535 · Cited by 190 · cited 7×
“The p.L552S mutation from our study was a missense mutation located on the transmembrane (cid:11) -helix of segment S5 forming the pore of the (cid:11) -subunits of the HERG channel [15,30].”
InfluentialWu, H., Lee, J., Vincent, L. G., Wang, Q., Gu, M., Lan, F., Churko, J. M., Sallam, K. I., Matsa, E., Sharma, A., et al. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.04.020 · Cited by 177 · cited 1×
“This phenomenon of a blunted (cid:12) -adrenergic response at single hiPSC-CMs has been reported in the pathogenic variants of mutations in titin mutations of dilated cardiomyopathy [45,46].”
BackgroundKoivumäki, J. T., Naumenko, N., Tuomainen, T., Takalo, J., Oksanen, M., Puttonen, K. A., Lehtonen, Š., Kuusisto, J., Laakso, M., Koistinaho, J., et al. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00080 · Cited by 171 · cited 1×
“To elucidate the arrhythmogenic mechanisms of the LQT2 mutation, we employed a previously published mathematical model of the electrophysiology and ion dynamics in hiPSC-CM (ref to [35]).”
MethodSelf-citationGenotype-Specific Onset of Arrhythmias in Congenital Long-QT Syndrome: Possible Therapy Implications
Tan, H. L., Bardai, A., Shimizu, W., Moss, A. J., Schulze‐Bahr, E., Noda, T., & Wilde, A. A. M. (2006) · Circulation · doi:10.1161/circulationaha.106.642694 · Cited by 143
Amin, A. S., Giudicessi, J. R., Tijsen, A. J., Spanjaart, A. M., Reckman, Y. J., Klemens, C. A., Tanck, M. W., Kapplinger, J. D., Hofman, N., Sinner, M. F., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr473 · Cited by 142
Kujala, K., Paavola, J., Lahti, A., Larsson, K., Pekkanen-Mattila, M., Viitasalo, M., Lahtinen, A. M., Toivonen, L., Kontula, K., Swan, H., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044660 · Cited by 136 · cited 1×
“Adrenaline caused more PL and OS arrhythmias in symptomatic CMs which increased the duration of one abnormal peak and therefore decreased the beat rate [44].”
BackgroundSelf-citationMehta, A., Ramachandra, C. J. A., Singh, P., Chitre, A., Lua, C. H., Mura, M., Crotti, L., Wong, P., Schwartz, P. J., Gnecchi, M., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx394 · Cited by 133
Antzelevitch, C. N., Yan, G., & Shimizu, W. (1999) · Journal of Electrocardiology · doi:10.1016/s0022-0736(99)90074-2 · Cited by 130
Thomsen, M. B., Volders, P. G. A., Beekman, J. D. M., Matz, J., & Vos, M. A. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.05.048 · Cited by 123
Fodstad, H., Swan, H., Laitinen, P. H., Piippo, K., Paavonen, K., Viitasalo, M. T., Toivonen, L. K., & KONTULA, K. K. (2004) · Annals of Medicine · doi:10.1080/17431380410032689 · Cited by 97 · cited 4×
“Genetic long QT syndrome (LQTS) is an autosomal dominant disorder with a prevalence of 1 in 2000 people in the Caucasian population and its prevalence has been estimated to be 1 in 250–500 in Finland [1–3].”
BackgroundInfluentialhERG 1b is critical for human cardiac repolarization
Jones, D. K., Liu, F., Vaidyanathan, R., Eckhardt, L. L., Trudeau, M. C., & Robertson, G. A. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1414945111 · Cited by 96
Ahola, A., Kiviaho, A., Larsson, K., Honkanen, M., Aalto‐Setälä, K., & Hyttinen, J. (2014) · BioMedical Engineering OnLine · doi:10.1186/1475-925x-13-39 · Cited by 95 · cited 1×
“WT) was characterized previously [28,31].”
Self-citationJohnson, D. M., Heijman, J., Bode, E. F., Greensmith, D. J., van der Linde, H. J., Abi‐Gerges, N., Eisner, D. A., Trafford, A. W., & Volders, P. G. A. (2012) · Circulation Research · doi:10.1161/circresaha.112.275735 · Cited by 93 · cited 1×
“The increased arrhythmia in both the asymptomatic and the symptomatic LQT2 hiPSC-CMs could be attributed to this increased beat rate variation as also reported in past studies [42,43].”
ResultHuman iPS cell model of type 3 long QT syndrome recapitulates drug-based phenotype correction
Malan, D., Zhang, M., Stallmeyer, B., Müller, J., Fleischmann, B. K., Schulze-Bahr, E., Sasse, P., & Greber, B. (2016) · Basic Research in Cardiology · doi:10.1007/s00395-016-0530-0 · Cited by 91
Clinical and Genetic Characteristics of Long QT Syndrome
Medeiros‐Domingo, A., Iturralde-Torres, P., & Ackerman, M. J. (2007) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(08)60010-9 · Cited by 85 · cited 1×
“These individuals may still have an increased risk for QT prolongation, could develop symptoms later in life and are at a higher risk of sudden death compared to non-carriers [20,21].”
BackgroundTrigger-specific risk factors and response to therapy in long QT syndrome type 2
Kim, J. A., Lopes, C. M. B., Moss, A. J., McNitt, S. A., Barsheshet, A., Robinson, J. L., Zaręba, W., Ackerman, M. J., Kaufman, E. S., Towbin, J. A., et al. (2010) · Heart Rhythm · doi:10.1016/j.hrthm.2010.09.011 · Cited by 85
Braam, S. R., Tertoolen, L. G. J., Casini, S., Matsa, E., Lu, H. R., Teisman, A. C. H., Passier, R. C., Denning, C. N., Gallacher, D. J., Towart, R., et al. (2012) · Stem Cell Research · doi:10.1016/j.scr.2012.08.007 · Cited by 78 · cited 1×
“The compensatory outward current would be increasing the repolarization reserve; a parameter reflecting the capacity of CMs to repolarize and a risk factor for arrhythmia when reduced [54].”
BackgroundClínica y genética en el síndrome de QT largo
Medeiros‐Domingo, A., Iturralde-Torres, P., & Ackerman, M. J. (2007) · Revista Española de Cardiología · doi:10.1157/13108280 · Cited by 77
Long QT syndrome: beyond the causal mutation
Amin, A. S., Pinto, Y. M., & Wilde, A. A. M. (2013) · The Journal of Physiology · doi:10.1113/jphysiol.2013.254920 · Cited by 75
High prevalence of four long QT syndrome founder mutations in the Finnish population
Marjamaa, A., Salomaa, V. V., Newton‐Cheh, C., Porthan, K., Reunanen, A., Karanko, H., Jula, A., Lahermo, P., Väänänen, H., Toivonen, L. K., et al. (2009) · Annals of Medicine · doi:10.1080/07853890802668530 · Cited by 74 · cited 2×
“Genetic long QT syndrome (LQTS) is an autosomal dominant disorder with a prevalence of 1 in 2000 people in the Caucasian population and its prevalence has been estimated to be 1 in 250–500 in Finland [1–3].”
BackgroundChen, X., Weaver, J., Bove, B. A., Vanderveer, L. A., Weil, S. C., Miron, A., Daly, M. B., & Godwin, A. K. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn022 · Cited by 72 · cited 1×
“The increased allelic imbalance in the BRCA1 gene is associated with increased breast cancer risk [38] and SNPs (single nucleotide polymorphsims) on the mutated allele of KCNQ1, causing allelic imbalance leading to a less severe form of LQT1.”
BackgroundEarle, N. J., Han, D. Y., Pilbrow, A. P., Crawford, J., Smith, W., Shelling, A. N., Cameron, V. A., Love, D. R., & Skinner, J. R. (2013) · Heart Rhythm · doi:10.1016/j.hrthm.2013.10.005 · Cited by 72 · cited 1×
“[4,11,13,14].”
Modeling of LMNA-Related Dilated Cardiomyopathy Using Human Induced Pluripotent Stem Cells
Shah, D., Virtanen, L., Prajapati, C., Kiamehr, M., Gullmets, J., West, G., Kreutzer, J., Pekkanen-Mattila, M., Heliö, T., Kallio, P., et al. (2019) · Cells · doi:10.3390/cells8060594 · Cited by 69 · cited 2×
“The MEA recording and analysis was performed as described in [33].”
MethodSelf-citationPhysiological genomics identifies genetic modifiers of long QT syndrome type 2 severity
Chai, S., Wan, X., Ramirez-Navarro, A., Tesar, P. J., Kaufman, E. S., Ficker, E., George, A. L., & Deschênes, I. (2018) · Journal of Clinical Investigation · doi:10.1172/jci94996 · Cited by 67 · cited 5×
“[4,11,13,14].”
BackgroundResultInfluentialPiippo, K., Laitinen, P. H., Swan, H., Toivonen, L. K., Viitasalo, M. T., Pasternack, M., Paavonen, K., Chapman, H., Wann, K. T., Hirvelä, E., et al. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00636-7 · Cited by 60 · cited 2×
“The p.L552S mutation from our study was a missense mutation located on the transmembrane (cid:11) -helix of segment S5 forming the pore of the (cid:11) -subunits of the HERG channel [15,30].”
BackgroundCalcium oscillations and T-wave lability precede ventricular arrhythmias in acquired long QT type 2
Němec, J., Kim, J. J., Gabris, B., & Salama, G. (2010) · Heart Rhythm · doi:10.1016/j.hrthm.2010.06.032 · Cited by 56 · cited 1×
“T-wave alternans, T-wave liability (beat-to-beat variation) or oscillation in the ECG have been reported to be a precursor to lethal arrhythmia and major cardiac events in humans and in rabbit LQT2 models [49,50].”
BackgroundLiu, W., Kim, T. Y., Huang, X., Liu, M. B., Koren, G., Choi, B., & Qu, Z. (2018) · The Journal of Physiology · doi:10.1113/jp275492 · Cited by 50 · cited 1×
“T-wave alternans, T-wave liability (beat-to-beat variation) or oscillation in the ECG have been reported to be a precursor to lethal arrhythmia and major cardiac events in humans and in rabbit LQT2 models [49,50].”
BackgroundFunctional Annotation of TNNT2 Variants of Uncertain Significance With Genome-Edited Cardiomyocytes
Lv, W., Qiao, L., Petrenko, N., Li, W., Owens, A. T., McDermott-Roe, C., & Musunuru, K. (2018) · Circulation · doi:10.1161/circulationaha.118.035028 · Cited by 35 · cited 1×
“This phenomenon of a blunted (cid:12) -adrenergic response at single hiPSC-CMs has been reported in the pathogenic variants of mutations in titin mutations of dilated cardiomyopathy [45,46].”
BackgroundPölönen, R.-P., Penttinen, K., Swan, H., & Aalto‐Setälä, K. (2018) · Stem Cells International · doi:10.1155/2018/9109503 · Cited by 34 · cited 1×
“The di (cid:11) erent type of CaT abnormalities (Figure 3C,D) were categorized into the following groups as also described previously [36,37]: oscillation (OS), if Ca 2 + oscillated for two or more peaks without reaching the baseline, low amplitude peaks (LP), which had small amplitude Ca 2 +…”
BackgroundSelf-citationPlatonov, P. G., McNitt, S. A., Polonsky, B., Rosero, S. Z., Kutyifa, V., Huang, A., Moss, A. J., & Zaręba, W. (2018) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.117.005918 · Cited by 33
Asahi, Y., Hamada, T., Hattori, A., Matsuura, K., Odaka, M., Nomura, F., Kaneko, T., Abe, Y., Takasuna, K., Sanbuissho, A., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-32921-1 · Cited by 23 · cited 2×
“This was done on a basis that the peak of the field potential (FP) repolarization was more closely related to 50% of the action potential duration [34] instead of the whole repolarization time.”
MethodGenotype-phenotype correlation in long QT syndrome
Baskar, S., & Aziz, P. F. (2015) · Global Cardiology Science and Practice · doi:10.5339/gcsp.2015.26 · Cited by 20
Li, Y., Sallam, K., Schwartz, P. J., & Wu, J. C. (2017) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.117.005398 · Cited by 20 · cited 1×
“Animal models also have ethical concerns, high costs and there is a need for models to replicate human physiology and genetic variation [23].”
BackgroundQuan, X., Bai, R., Lü, J., Patel, C., Liu, N., Ruan, Y., Chen, B.-D., Ruan, L., & Zhang, C. (2009) · Cell Communication & Adhesion · doi:10.1080/15419060903118567 · Cited by 17 · cited 1×
“A study on a canine LQT2 model reported pharmacologically enhanced connexin 43 gap junction coupling, prevented arrhythmias by reducing the DOR [53].”
BackgroundKuusela, J., Kim, J., Räsänen, E., & Aalto‐Setälä, K. (2016) · Stem Cell Reviews and Reports · doi:10.1007/s12015-016-9686-0 · Cited by 17 · cited 1×
“A past study of LQT1 symptomatic and asymptomatic hiPSC-CMs on MEA did not report any major di (cid:11) erences in the e (cid:11) ects of the application of IKs blockers [55].”
BackgroundSelf-citationPenttinen, K., Siirtola, H., Àvalos-Salguero, J., Vainio, T., Juhola, M., & Aalto‐Setälä, K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135806 · Cited by 16 · cited 1×
“The di (cid:11) erent type of CaT abnormalities (Figure 3C,D) were categorized into the following groups as also described previously [36,37]: oscillation (OS), if Ca 2 + oscillated for two or more peaks without reaching the baseline, low amplitude peaks (LP), which had small amplitude Ca 2 +…”
BackgroundSelf-citationCellular Mechanisms of Torsade de Pointes
Poelzing, S., & ROSENBAUM, D. S. (2005) · Novartis Foundation symposium · doi:10.1002/047002142x.ch16 · Cited by 14 · cited 2×
“Another hypothesis for TdP is the reduced dispersion of repolarization (DOR) across the heart wall, where some CMs repolarize more rapidly than others with prolonged repolarization [51,52].”
BackgroundCellular mechanisms of Torsade de Pointes.
加藤, 郁., & ROSENBAUM, D. S. (2005) · PubMed · doi:10.20555/jtsjs.116.0_118
Cited by
Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy
Nicholson, M. W., Ting, C.-Y., Chan, D. Z. H., Cheng, Y.-C., Lee, Y.-C., Hsu, C.-C., Huang, C.-Y., & Hsieh, P. C. H. (2022) · Cells · doi:10.3390/cells11111853 · Cited by 65
Stem Cell-Based Disease Modeling and Cell Therapy
Bai, X. (2020) · Cells · doi:10.3390/cells9102193 · Cited by 36
Long QT syndrome – Bench to bedside
Ponce‐Balbuena, D., & Deschênes, I. (2021) · Heart Rhythm O2 · doi:10.1016/j.hroo.2021.01.006 · Cited by 32
Arrhythmia Mechanisms in Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes
Paci, M., Penttinen, K., Pekkanen-Mattila, M., & Koivumäki, J. T. (2020) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000972 · Cited by 26
Self-citationData analytics for cardiac diseases
Juhola, M., Joutsijoki, H., Penttinen, K., Shah, D. A., Pölönen, R.-P., & Aalto‐Setälä, K. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.105218 · Cited by 26
Self-citation
Metadata
- Authors
- Shah, D., Prajapati, C., Penttinen, K., Cherian, R. M., Koivumäki, J. T., Alexanova, A., Hyttinen, J., & Aalto-Setälä, K.
- Affiliations
- Tampere University (FI)
- Faculty of Medicine and Health Technology and BioMediTech Institute, Tampere University, 33520 Tampere, Finland
- Corresponding author
- Shah, Disheet
- ORCID
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2020-05-07
- Volume
- 9
- Issue
- 5
- Pages
- 1153
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC7290503
- OpenAlex
- W3020941314
- Cited by
- 31
- References
- 57
- Citations by year
- 2026: 6 · 2025: 1 · 2024: 3 · 2023: 5 · 2022: 6 · 2021: 5 · 2020: 5
- FWCI
- 3.25
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Tampere University Institutional Repository (Tampere University) (submittedVersion, cc-by)
- Funders
- Yrjö Jahnssonin Säätiö
- Aarne Koskelon Säätiö
- Suomen Kulttuurirahasto
- Paavo Nurmen Säätiö
- Pirkanmaan Sairaanhoitopiiri
- Opetushallitus
- Pirkanmaan Rahasto
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Keywords
- long QT syndrome type 2, hERG, hiPSC-derived cardiomyocytes, arrhythmia susceptibility, adrenaline-induced arrhythmia, calcium transients, asymptomatic mutation carriers, in silico modeling
- MeSH terms
- Adult, Alleles, Cell Aggregation, Female, Humans, Long QT Syndrome, Male, Middle Aged, Models, Biological, Mutation, Ion Channel Gating, Case-Control Studies, Myocytes, Cardiac, Induced Pluripotent Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.